Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in wAMD | Business Wire

Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in wAMD | Business Wire: Vitrisa Therapeutics, Inc., a Company focused on developing a suite of platform technologies optimized for ocular therapeutics and an associated pipel